PROVIDER PROFILE · NPI 1013171313
Sarat ChandarlapatyM.D., PH.D.
PRESCRIBING · PART D · 2024
Total Rx claims
51
Beneficiaries
—
Total drug cost
$454K
Distinct drugs
4
Brand share
47.1%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
CROSS-REFERENCE